News
Long term Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders know that all too well, since the share price is down considerably over three years. Regrettably, they have had to cope with a 61% drop ...
Researchers have found in a new study that glass ionomer containing BioUnion fillers demonstrated ... Tokyo), and GIC with BioUnion™ fillers (GIC-Bio; Caredyne Restore, GC Corporation). A 4-week ...
Bio-Rad Laboratories, Inc.’s BIO Clinical Diagnostics business is back to its usual growth trajectory post-pandemic while maintaining a strong market position worldwide for key platforms.
Containment cabinets in a BSL-3 laboratory, prior to the construction of modern BSL-4 labs. At first glance, the lab looks like any other. The refrigerators, centrifuges, and computers are all ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Foresight™ Pro 45 cm inner diameter (ID) ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results